American Society of Clinical Oncology

SHERPA: White

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. O'Reilly
    O'Reilly
  4. Saltz
    Saltz
  5. Bajorin
    Bajorin
  6. Kris
    Kris
  7. Hudis
    Hudis
  8. Morris
    Morris
  9. Rosenberg
    Rosenberg
  10. Robson
    Robson

Groups

  1. Department of Medicine (6408)
  2. Solid Tumor Oncology Division (5546)
  3. Survivorship Research (1999)
  4. Genitourinary Oncology Service (1768)
  5. Surgery (1642)
  6. Epidemiology and Biostatistics (1497)
  7. GSK Faculty (1389)
  8. Population Sciences Research Program (1381)
  9. Gastrointestinal Oncology Service (1356)
  10. Hematologic Malignancies, Division of (1286)
Search Within
Formats
  1. Meeting Abstract (6344)
  2. Journal Article (2591)
  3. Editorial (79)
  4. Review (70)
  5. Guidelines (55)
  6. Correspondence (49)
  7. Miscellaneous (4)
  8. Conference Paper (3)
Groups
  1. Department of Medicine (6408)
  2. Solid Tumor Oncology Division (5546)
  3. Survivorship Research (1999)
  4. Genitourinary Oncology Service (1768)
  5. Surgery (1642)
  6. Epidemiology and Biostatistics (1497)

More Groups

People
  1. Robert Motzer (451)
  2. Howard Scher (334)
  3. Eileen O'Reilly (308)
  4. Leonard Saltz (283)
  5. Dean Bajorin (280)
  6. Mark Kris (253)

More People

Years
  1. 2025 (303)
  2. 2024 (554)
  3. 2023 (580)
  4. 2022 (554)
  5. 2021 (504)
  6. 2020 (539)

More Years

Publications
  1. Journal of Clinical Oncology (8712)
  2. JCO Precision Oncology (174)
  3. Journal of Oncology Practice (124)
  4. American Society of Clinical Oncology Educational Book (112)
  5. JCO Clinical Cancer Informatics (54)
  6. JCO Oncology Practice (12)

More Publications

Results (9195)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis after mismatched unrelated donor peripheral blood stem cell transplantation
    Journal Article

    Al Malki, M. M.; Bo-Subait, S.; Logan, B.; Olson, J.; Kou, J.; Smith, S.; Leckrone, E.; Wu, J.; Stefanski, H. E.; Auletta, J. J.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Phase II (Alliance A091802) randomized trial of avelumab plus cetuximab versus avelumab alone in advanced cutaneous squamous cell carcinoma
    Journal Article

    Zandberg, D. P.; Allred, J. B.; Rosenberg, A. J.; Kaczmar, J. M.; Swiecicki, P.; Julian, R. A.; Poklepovic, A. S.; Bauman, J. R.; Phan, M. D.; Saba, N. F.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Early-phase trials in Journal of Clinical Oncology
    Editorial

    Stinchcombe, T. E.; Fleming, G. F.; Craddock, C.; Ko, A. H.; O'Reilly, E. M.; Maki, R. G.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Pasritamig, a first-in-class, bispecific T-cell engager targeting human kallikrein 2, in metastatic castration-resistant prostate cancer: A phase I study
    Journal Article

    Stein, M. N.; Vinceneux, A.; Robbrecht, D.; Doger, B.; Autio, K. A.; Schweizer, M. T.; Calvo, E.; Medina, L.; Van Dongen, M.; Deville, J. L.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Health information disparities among Asian American people with cancer
    Journal Article

    Wang, S.; Kohli, K.; Shin, E. D.; Feliciano, E. J. G.; Diamond, L. C.; Dee, E. C.
    JCO Oncology Practice (2025)

    Fulltext@MSK | Save
  • Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: ASCO Guideline Clinical Insights
    Guidelines

    Tew, W. P.; Lacchetti, C.; Gaillard, S.
    JCO Oncology Practice (2025)

    Fulltext@MSK | Save
  • Sequential antibody-drug conjugate therapy in patients with metastatic breast cancer treated with sacituzumab govitecan and trastuzumab deruxtecan
    Journal Article

    Mai, N.; Lieberman, M. M. K.; Ferraro, E.; Bromberg, M.; Chen, Y.; Razavi, P.; Modi, S.; Chandarlapaty, S.; Walsh, E. M.; Drago, J. Z.
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Breast cancer among older adults in Asia
    Editorial

    Jacomina, L. E.; Tison, N. R.; Feliciano, E. J. G.; Magsanoc-Alikpala, M. J. K.; Dee, E. C.
    JCO Global Oncology (2025)

    Fulltext@MSK | Save
  • ORCHARD: Osimertinib plus necitumumab in patients with epidermal growth factor receptor–mutated advanced non–small cell lung cancer with a secondary epidermal growth factor receptor alteration whose disease had progressed on first-line osimertinib
    Journal Article

    Riess, J. W.; de Langen, A. J.; Ponce, S.; Goldberg, S. B.; Piotrowska, Z.; Goldman, J. W.; Le, X.; Cho, B. C.; Yoneshima, Y.; Ambrose, H.; more...
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Allogeneic chimeric antigen receptor T-cell products cemacabtagene ansegedleucel/ALLO-501 in relapsed/refractory large B-cell lymphoma: Phase I experience from the ALPHA2/ALPHA clinical studies
    Journal Article

    Locke, F. L.; Munoz, J. L.; Tees, M. T.; Lekakis, L. J.; de Vos, S.; Nath, R.; Stevens, D. A.; Malik, S. A.; Shouse, G. P.; Hamadani, M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save